My Research Legacy Pilot Study

March 4, 2021 updated by: American Heart Association
The My Research Legacy Pilot Study will establish a participant registry that collects self-reported health data and answers to online survey questions about individual daily choices, diets, and exercise; data from wearable devices; and, (optional) data from genome sequencing analysis. Individuals under the age of 50 who meet eligibility criteria will answer questions using the American Heart Association's (AHA) Life's Simple 7™ My Life Check v4.0 three times over the course of 6 months and transmit data from a Fitbit Charge 2 device. All other individuals who are interested in the study and meet entry criteria may also enroll.

Study Overview

Detailed Description

2,000 Participant My Research Legacy Pilot Study

  1. Day 0 - Enroll online, complete AHA's Life's Simple 7™ Survey Prospective participants will enroll in the research initiative via the My Research Legacy website (MyResearchLegacy.org). They will go through an online process in which they will answer brief, pre-qualifying questions before consenting to participate in the study.

    • Participants will attest to their age and US residence, and will provide a self-reported diagnosis of cardiovascular disease (myocardial infarction, atrial fibrillation, aortic dissection, systolic congestive heart failure/cardiomyopathy) and/or stroke.
    • Eligible participants will read and sign an online consent form.
    • Within the participant console, the participants will answer AHA's Life's Simple 7™ My Life Check v4.0 assessment.
    • Participants will be asked during the consent process if they will consent to provide medical records relevant to their diagnosis.
  2. Day 90 Complete AHA's Life's Simple 7™ My Life Check v4.0 assessment; Start transmission from the Fitbit Charge 2.
  3. Online Survey and contact Day 180 after enrollment, participants will receive an email requesting that they visit the participant console to repeat AHA's Life's Simple 7™ My Life Check v4.0 survey. Participants also have the option of determining whether or not they want to be contacted for future studies.

Study Type

Observational

Enrollment (Actual)

2267

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 89 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All individuals equal to or older than 18 years but younger than 50 years of age who have a history of, or have, an aortic dissection; or systolic heart failure/cardiomyopathy; or atrial fibrillation; or myocardial infarction; or stroke. All other individuals equal to or older than 18 years who don't meet the above health criteria but are interested in the study.

Description

Inclusion Criteria:

  1. Age > or = to 18 years but < 50 years.
  2. History of one (or more) of the following:

    1. Myocardial infarction
    2. Stroke
    3. Aortic dissection
    4. Systolic heart failure/cardiomyopathy
    5. Atrial fibrillation
  3. Individuals of any age > or = 18 years who don't have above medical conditions but want to participate in the study.
  4. Access to a computer and/or cell phone with internet access.

Exclusion Criteria:

  1. Unwillingness to sign informed consent
  2. No access to a computer and/or cell phone with internet access.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Myocardial infarction
Individuals with myocardial infarction before age 50 years.
Stroke
Individuals with stroke before age 50 years
Aortic dissection
Individuals with aortic dissection before age 50 years
Systolic heart failure
Individuals with systolic heart failure/dilated cardiomyopathy before age 50 years.
Atrial fibrillation
Individuals with atrial fibrillation before age 50 years

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
study retention
Time Frame: 6 months
continues to engage with study after 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in answers to AHA's Life's Simple 7™ My Life Check v4.0
Time Frame: 6 months
answers to second and other surveys
6 months
Duration of time Fitbit Charge 2 used by participants
Time Frame: 6 months
recorded time
6 months
Change in Fitbit Charge 2 step count
Time Frame: 6 months
recorded steps
6 months
Percent of individuals that initiate but don't complete online process
Time Frame: 6 months
number that start but don't finish first surveys
6 months
Activity duration
Time Frame: 6 months
Daily, weekly, monthly activity from Fitbit Charge 2
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jane A Leopold, MD, American Heart Association

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2016

Primary Completion (Actual)

October 30, 2018

Study Completion (Actual)

October 30, 2018

Study Registration Dates

First Submitted

November 4, 2016

First Submitted That Met QC Criteria

November 4, 2016

First Posted (Estimate)

November 8, 2016

Study Record Updates

Last Update Posted (Actual)

March 8, 2021

Last Update Submitted That Met QC Criteria

March 4, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be made available to other researchers.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Subscribe